General MedicationsINJECTIONStandard
MELPHALAN HYDROCHLORIDE
MELPHALAN HYDROCHLORIDE
Standard Dose
EQ 50MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MELPHALAN HYDROCHLORIDE is listed in Drugs@FDA under application 215024 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MELPHALAN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/VIAL Sponsor HETERO LABS Submission history Latest submission status date: 2024-05-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview MELPHALAN HYDROCHLORIDE is listed in Drugs@FDA under application 215024 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MELPHALAN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/VIAL Sponsor HETERO LABS Submission history Latest submission status date: 2024-05-23 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.